Study Details

Back
Study ID ADV-KT-13-01
Study Title A Multicenter, Randomized, Comparison, Open-label, Phase IV Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
Clinicaltrials.gov Identifier NCT02034747
Compound Name FK506E / tacrolimus extended-release
Medical Indication or Disease Prevention of rejection after organ transplant
Study Sponsor Astellas Pharma Korea, Inc.
Collaborator Not Applicable
Study Start Date 21-Nov-2013
Study Completion Date 07-Nov-2015
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS